PHVS (PHVS) Stock Price & Analysis
PHVS (PHVS) fell 1.15% to USD 35.25 as of September 8, 2026 at 08:19 UTC, according to Nexqual real-time market data.
PHVS last closed at USD 35.25; the session ranged USD 35.21–36.39 on volume of 483,983 shares. Market capitalization is —, with a 52-week range of USD 20.65–38.13 (NMS). Source: Nexqual, September 8, 2026 at 08:19 UTC.
Key Statistics (as of September 8, 2026 at 08:19 UTC)
| Price | USD 35.25 |
|---|---|
| Change | ▼ 1.15% (down) |
| Previous Close | USD 35.25 |
| Open | USD 35.25 |
| Day Range | USD 35.21 – 36.39 |
| 52-Week Range | USD 20.65 – 38.13 |
| Volume | 483,983 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (PHVS)
Nexqual's technical model rates PHVS "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 08:19 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 48.75 (neutral) |
| vs SMA50 | Above (USD 34.79) |
| MACD | 0.28 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| EWTX | Edgewise Therapeutics, Inc. | USD 43.07 | ▲ 2.6% |
| CGEM | Cullinan Therapeutics, Inc. | USD 22.09 | ▼ 1.07% |
| IMCR | Immunocore Holdings plc | USD 36.13 | ▼ 3.32% |
| ORIC | Oric Pharmaceuticals, Inc. | USD 12.86 | ▼ 2.06% |
| TYRA | Tyra Biosciences, Inc. | USD 28.65 | ▲ 14.01% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 08:19 UTC. This page is informational and not investment advice.